COVID-19大流行之前和期间的献血者特征和血液安全:BEST合作国际调查

IF 1.6 4区 医学 Q3 HEMATOLOGY
Vox Sanguinis Pub Date : 2025-08-01 Epub Date: 2025-06-04 DOI:10.1111/vox.70055
Antoine Lewin, Mindy Goldman, Sheila F O'Brien, David O Irving, Ralph Vassallo, Pierre Tiberghien, Naoko Goto, Allison Waters, Thijs van de Laar, Cyril Jacquot, Roberta Fachini, Marc Germain
{"title":"COVID-19大流行之前和期间的献血者特征和血液安全:BEST合作国际调查","authors":"Antoine Lewin, Mindy Goldman, Sheila F O'Brien, David O Irving, Ralph Vassallo, Pierre Tiberghien, Naoko Goto, Allison Waters, Thijs van de Laar, Cyril Jacquot, Roberta Fachini, Marc Germain","doi":"10.1111/vox.70055","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Early in the COVID-19 pandemic, blood suppliers faced unique challenges meeting changing demand while maintaining safety for donors, recipients and staff. Actions taken may have altered the composition of the donor base and the frequency of confirmed-positive infectious disease marker (IDM) rates. No studies have evaluated the impact of the pandemic on donations, donor demographics and blood safety across several countries.</p><p><strong>Materials and methods: </strong>Whole blood/red blood cell (RBC) donors and donations and confirmed IDM reactivity recorded during from 11 March 2019 to 11 September 2019 (\"pre-pandemic period\") and from 11 March 2020 to 11 September 2020 (\"pandemic period\") were collected by 11 blood services participating in the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.</p><p><strong>Results: </strong>Eleven blood services from nine countries reported on over 4 million donations per period. On average, donations dropped by 4.0% between pre-pandemic and pandemic periods, driven by fewer donations from active repeat donors (-5.6%) and first-time [FT] donors (-14.0%) but partially offset by more donations from lapsed donors (+15.7%). The decline was also driven by fewer donations from male donors (-7.6%) and younger donors (i.e., 16-25 years: -19.0%). Overall, the rate of confirmed IDM positivity dropped from 100.0 to 88.6 per 100,000 donors (-11.4%) between pre-pandemic and pandemic periods.</p><p><strong>Conclusion: </strong>Early in the pandemic, blood donations, particularly from FT donors, decreased. In future respiratory virus pandemics, blood banks should anticipate changes in demand, collection site locations and capacity and donor behaviour. Unlike results in acute catastrophes, lower rates of confirmed IDM positivity were observed, in part related to lower numbers of FT, male and younger donors.</p>","PeriodicalId":23631,"journal":{"name":"Vox Sanguinis","volume":" ","pages":"776-783"},"PeriodicalIF":1.6000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Blood donor characteristics and blood safety before and during the COVID-19 pandemic: A BEST Collaborative international survey.\",\"authors\":\"Antoine Lewin, Mindy Goldman, Sheila F O'Brien, David O Irving, Ralph Vassallo, Pierre Tiberghien, Naoko Goto, Allison Waters, Thijs van de Laar, Cyril Jacquot, Roberta Fachini, Marc Germain\",\"doi\":\"10.1111/vox.70055\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and objectives: </strong>Early in the COVID-19 pandemic, blood suppliers faced unique challenges meeting changing demand while maintaining safety for donors, recipients and staff. Actions taken may have altered the composition of the donor base and the frequency of confirmed-positive infectious disease marker (IDM) rates. No studies have evaluated the impact of the pandemic on donations, donor demographics and blood safety across several countries.</p><p><strong>Materials and methods: </strong>Whole blood/red blood cell (RBC) donors and donations and confirmed IDM reactivity recorded during from 11 March 2019 to 11 September 2019 (\\\"pre-pandemic period\\\") and from 11 March 2020 to 11 September 2020 (\\\"pandemic period\\\") were collected by 11 blood services participating in the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.</p><p><strong>Results: </strong>Eleven blood services from nine countries reported on over 4 million donations per period. On average, donations dropped by 4.0% between pre-pandemic and pandemic periods, driven by fewer donations from active repeat donors (-5.6%) and first-time [FT] donors (-14.0%) but partially offset by more donations from lapsed donors (+15.7%). The decline was also driven by fewer donations from male donors (-7.6%) and younger donors (i.e., 16-25 years: -19.0%). Overall, the rate of confirmed IDM positivity dropped from 100.0 to 88.6 per 100,000 donors (-11.4%) between pre-pandemic and pandemic periods.</p><p><strong>Conclusion: </strong>Early in the pandemic, blood donations, particularly from FT donors, decreased. In future respiratory virus pandemics, blood banks should anticipate changes in demand, collection site locations and capacity and donor behaviour. Unlike results in acute catastrophes, lower rates of confirmed IDM positivity were observed, in part related to lower numbers of FT, male and younger donors.</p>\",\"PeriodicalId\":23631,\"journal\":{\"name\":\"Vox Sanguinis\",\"volume\":\" \",\"pages\":\"776-783\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vox Sanguinis\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/vox.70055\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/4 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vox Sanguinis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/vox.70055","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/4 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景和目标:在2019冠状病毒病大流行初期,血液供应商面临着独特的挑战,既要满足不断变化的需求,又要保证献血者、接受者和工作人员的安全。所采取的行动可能改变了供体基础的组成和确诊阳性传染病标志物(IDM)率的频率。没有研究评估过疫情对若干国家献血、献血者人口统计和血液安全的影响。材料和方法:2019年3月11日至2019年9月11日(“大流行前期”)和2020年3月11日至2020年9月11日(“大流行期”)期间记录的全血/红细胞(RBC)献血者和献血者以及确认的IDM反应性,由参加“卓越生物医学促进更安全输血”(BEST)协作项目的11家血液服务机构收集。结果:来自9个国家的11个血液服务机构报告了每个时期超过400万次的献血量。在大流行前和大流行期间,捐款平均下降4.0%,原因是活跃的重复捐助者的捐款减少(-5.6%)和首次捐助者的捐款减少(-14.0%),但部分被失效捐助者的捐款增加(+15.7%)所抵消。男性献血者的捐赠减少(-7.6%)和年轻献血者(即16-25岁:-19.0%)也造成了下降。总体而言,在大流行前和大流行期间,确诊的IDM阳性比率从每10万名捐助者100.0人降至88.6人(-11.4%)。结论:在大流行早期,献血者,特别是来自FT献血者的献血者减少了。在未来的呼吸道病毒大流行中,血库应预测需求、采集地点、能力和献血者行为的变化。与急性灾难的结果不同,观察到的IDM确诊阳性率较低,部分原因是FT、男性和年轻献血者数量较少。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Blood donor characteristics and blood safety before and during the COVID-19 pandemic: A BEST Collaborative international survey.

Background and objectives: Early in the COVID-19 pandemic, blood suppliers faced unique challenges meeting changing demand while maintaining safety for donors, recipients and staff. Actions taken may have altered the composition of the donor base and the frequency of confirmed-positive infectious disease marker (IDM) rates. No studies have evaluated the impact of the pandemic on donations, donor demographics and blood safety across several countries.

Materials and methods: Whole blood/red blood cell (RBC) donors and donations and confirmed IDM reactivity recorded during from 11 March 2019 to 11 September 2019 ("pre-pandemic period") and from 11 March 2020 to 11 September 2020 ("pandemic period") were collected by 11 blood services participating in the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.

Results: Eleven blood services from nine countries reported on over 4 million donations per period. On average, donations dropped by 4.0% between pre-pandemic and pandemic periods, driven by fewer donations from active repeat donors (-5.6%) and first-time [FT] donors (-14.0%) but partially offset by more donations from lapsed donors (+15.7%). The decline was also driven by fewer donations from male donors (-7.6%) and younger donors (i.e., 16-25 years: -19.0%). Overall, the rate of confirmed IDM positivity dropped from 100.0 to 88.6 per 100,000 donors (-11.4%) between pre-pandemic and pandemic periods.

Conclusion: Early in the pandemic, blood donations, particularly from FT donors, decreased. In future respiratory virus pandemics, blood banks should anticipate changes in demand, collection site locations and capacity and donor behaviour. Unlike results in acute catastrophes, lower rates of confirmed IDM positivity were observed, in part related to lower numbers of FT, male and younger donors.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Vox Sanguinis
Vox Sanguinis 医学-血液学
CiteScore
4.40
自引率
11.10%
发文量
156
审稿时长
6-12 weeks
期刊介绍: Vox Sanguinis reports on important, novel developments in transfusion medicine. Original papers, reviews and international fora are published on all aspects of blood transfusion and tissue transplantation, comprising five main sections: 1) Transfusion - Transmitted Disease and its Prevention: Identification and epidemiology of infectious agents transmissible by blood; Bacterial contamination of blood components; Donor recruitment and selection methods; Pathogen inactivation. 2) Blood Component Collection and Production: Blood collection methods and devices (including apheresis); Plasma fractionation techniques and plasma derivatives; Preparation of labile blood components; Inventory management; Hematopoietic progenitor cell collection and storage; Collection and storage of tissues; Quality management and good manufacturing practice; Automation and information technology. 3) Transfusion Medicine and New Therapies: Transfusion thresholds and audits; Haemovigilance; Clinical trials regarding appropriate haemotherapy; Non-infectious adverse affects of transfusion; Therapeutic apheresis; Support of transplant patients; Gene therapy and immunotherapy. 4) Immunohaematology and Immunogenetics: Autoimmunity in haematology; Alloimmunity of blood; Pre-transfusion testing; Immunodiagnostics; Immunobiology; Complement in immunohaematology; Blood typing reagents; Genetic markers of blood cells and serum proteins: polymorphisms and function; Genetic markers and disease; Parentage testing and forensic immunohaematology. 5) Cellular Therapy: Cell-based therapies; Stem cell sources; Stem cell processing and storage; Stem cell products; Stem cell plasticity; Regenerative medicine with cells; Cellular immunotherapy; Molecular therapy; Gene therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信